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Infantile ﬁbrosarcoma (IF) is a rare tumor presenting in infants and young children that most commonly
develops in the extremities. Intestinal IF has been rarely described, with all previous cases presenting
with obstruction, perforation, or both. We present two cases of intestinal IF recently managed at our
institution. The ﬁrst was a previously healthy 4-month old female with an incidentally discovered
abdominal mass. This tumor was found to arise from the jejunum with no additional visceral involve-
ment. The second was a 15-day old female with a distal small bowel mass that resulted in an ileal
obstruction. Pathologic evaluation of both tumors revealed a myxoid spindle cell histology, and genetic
analyzes demonstrated the t(12; 15) translocation, conﬁrming IF. We discuss the presentations of these
patients, and describe the recommended treatment strategies for patients with intestinal IF.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Infantile ﬁbrosarcoma (IF) is a rare, non-rhabdomyosarcomatous
soft tissue sarcoma that typically presents in infants and children
before 5 years of age [1e3]. Most tumors arise from the extremities
or the trunk, although a small number of case reports describing IF
arising from the bowel have been documented (Table 1) [4e13].
These cases have all presented with intestinal obstruction or
perforation [5e13]. We present here two cases of small bowel in-
fantile ﬁbrosarcoma, one of which is the ﬁrst reported presentation
as an asymptomatic, incidentally discovered abdominal mass.
1. Case reportepatient 1
A previously healthy 4 month old female was noted to have an
abdominal mass by her primary care provider at a routine well-child
visit. Her prenatal course had been unremarkable and she was
delivered at term by Caesarean-section for breech position. She had
been eating well and gaining appropriate weight. On physical exam-
ination she had a palpable,ﬁrm, non-tendermass occupying the rightBY-NC-ND license (http://
gery, Nationwide Children’s
43205, USA. Tel.: þ614 722
ns.org (J.H. Aldrink).
Published by Elsevier Inc. All righthemi-abdomen, without any identiﬁable lymphadenopathy or other
pertinent ﬁndings. An ultrasound was obtained identifying a heter-
ogenousmassofunclearorigin, appearing tobedistinct fromthe liver,
kidneys, and spleen. Further cross-sectional imaging with computed
tomography of the chest, abdomen, and pelvis identiﬁed a heterog-
enous right-sided abdominal mass measuring 6.9  8.1  8.3 cm in
size, possibly arising from the ovary (Fig. 1). Tumor markers were
obtained and included alpha fetoprotein (77.1 ng/mL; reference
<87ng/mL) [14], beta-humanchorionic gonadotropin (<2.0mIU/mL;
reference<10 mIU/mL), and urine catecholamines (vanillylmandelic
acid to creatinine ratio: 9.4; homovanillic acid to creatinine ratio:
24.6; references: <20.1 and <30.1, respectively), all of which were
within age-based normal limits.
Surgical consultation was obtained, and she underwent explo-
ration of her abdomen via a Pfannenstiel skin incision. Clear peri-
toneal ﬂuid was collected and sent for cytology. Upon visual
inspection, all solid organs including ovaries appeared normal. The
small bowel was eviscerated and the mass was identiﬁed arising
from the mid-jejunum along the anti-mesenteric surface. This
portion of the jejunum was resected with 3 cm margins and a
primary stapled anastomosis was performed (Fig. 2). Her post-
operative course was uneventful and she was discharged home on
post-operative day 3.
Subsequent pathology described amyxoid spindle cell neoplasm
primarily invading the muscularis propria with a mitotic count ofs reserved.
Table 1
Previously reported cases of intestinal infantile ﬁbrosarcoma.
Study Age Gender Presentation Location Treatment/outcome
Wright, 1971 [5] 16 months M Vomiting without obstruction Duodenum Pancreaticoduodenectomy, well at 24 months
Shearburn et al., 1975 [6] 1 day F Obstruction Duodenum Pancreaticoduodenectomy, well at 14 months
Sherman and Neustein, 1985 [7] 1 day M Obstruction Ileum Resection, well at 3 years
Shima et al., 2003 [8] 1 day F Perforation, meconium peritonitis Jejunum Resection, full recovery
Buccoliero et al., 2008 [9] 3 days M Perforation Ascending colon Ileocolectomy, well at 12 months
Islam et al., 2008 [10] 0 days M Meconium peritonitis Descending colon Resection, well at 5 years
van Niekerk et al., 2010 [11] 2 days M Obstruction Ileum Ileocecectomy, well at 9 months
Rizkalla et al., 2011 [12] 5 days M Perforation Ileum Resection, well at 12 months
Kim et al., 2013 [13] 2 days M Pneumo-peritoneum Sigmoid colon Sigmoid colectomy, well at 1 year
Present study e patient 1 4 months F Asymptomatic abdominal mass Jejunum Resection, full recovery
Present study e patient 2 15 days F Obstruction Ileum Ileocecectomy, full recovery
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Immunohistochemistry (IHC) was weakly positive for smooth
muscle actin (SMA) and CD117. Reverse transcriptaseepolymerase
chain reaction (RT-PCR) was positive for the t(12; 15) translocation
that is commonly identiﬁed in IF. There were no tumor cells
observed in the peritoneal ﬂuid. Post-operative positron emission
tomography computed tomography (PET-CT) did not identify re-
sidual tumor, involvement of lymph nodes, or metastatic disease. In
the setting of negative margins and the absence of residual or
metastatic disease, close observationwithout adjuvant therapy was
deemed the most appropriate course. Her follow up will consist of
physical exam and serial imaging for at least two years to monitor
for tumor recurrence.
2. Case reportepatient 2
A 12-day old term infant with no pregnancy or vaginal delivery
complications was admitted for poor feeding, abdominal disten-
sion, and dehydration. An abdominal x-ray demonstrated a distalFig. 1. Computed tomographic image of intra-abdominal mass seen on pre-operative
evaluation for Patient 1.small bowel obstruction, which was conﬁrmed by an upper
gastrointestinal contrast study. She was taken to the operating
room for abdominal exploration, andwas found to have a distal ileal
mass resulting in obstruction and focal intestinal ischemia. An
ileocecectomy was performed with a primary anastomosis. No
other masses or abnormalities were observed during complete
exploration of the abdomen. Her post-operative coursewas marked
by slow progress tolerating oral feedings and she was discharged
home on post-operative day 9.Fig. 2. (a) Segment of jejunum from Patient 1 with tumor [8  5.5  5.5 cm] arising
from anti-mesenteric surface. (b) Cut surface showing a bulging surface composed of
ﬁrm white-tan whorled ﬁbrous tissue.
Fig. 3. Spindled cell tumor from Patient 1 with fascicular appearance and scattered
blood vessels (Hematoxylin & Eosin, 10).
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that was located at the ileocecal valve (Fig. 4). It was composed of
proliferating spindle cells forming fascicles that invaded through
the cecal subserosa and extended along the subserosa of the ileum
and appendix, with amitotic count of 6 per 10HPF. IHCwas negative
for all markers evaluated (ALK1, myogenin, beta catenin, CD117,
smooth muscle actin and muscle speciﬁc actin). Fluorescent in situ
hybridization analysis demonstrated the t(12; 15) translocation.
Post-operative imaging did not demonstrate any residual intra-
abdominal tumor, lymphadenopathy, or evidence of distant spread.
Again, close observation without adjuvant therapy was determined
to be the most appropriate course.3. Discussion
IF is an extremely rare malignancy affecting infants and young
children and is characterized by a rapidly growing invasive mass.
Although it most commonly presents in the extremities, it has been
known to arise in virtually all other areas of the body [4]. Intra-
abdominal IF is particularly rare andmost cases tend to arise fromsoft
tissue structures rather than bowel or solid organs. There have beenFig. 4. Distal ileum, cecum, and proximal ascending colon from Patient 2 with tumor
[3.3  3.2  4.5 cm] tan-yellow mass located at the ileocecal valve.fewcase reports of IF involvingeither the small intestine or colon, and
these were all identiﬁed due to either extrinsic bowel obstruction or
perforation (Table 1) [5e13]. Furthermore, these patientswere nearly
all identiﬁed at parturition or within the ﬁrst several days of life,
similar to the second patient described in our report. However, there
are no prior reports of an intestinal IF presenting as an uncomplicated
abdominal mass as was the case in our ﬁrst patient.
The differential diagnosis for an infant with a solid abdominal
mass includes neuroblastoma, Wilms tumor, hepatoblastoma,
rhabdomyosarcoma, and lymphoma.With respect to tumors arising
from the small intestine, in infants these are most typically leio-
myomas, leiomyosarcomas, or other tumors of mesenchymal origin,
all of which are extremely uncommon [15].
Evaluation of an abdominal mass begins with radiographic im-
aging to evaluate the source of the mass and also to determine the
presence of metastatic spread both locally and at distant sites. Tu-
mor markers can aid with diagnosis and post-therapeutic surveil-
lance for some malignancies including hepatoblastoma and
neuroblastoma. In the ﬁrst case presented, preoperative imaging
did not demonstrate lymphadenopathy, local invasion, or distant
spread, and all tumor markers were normal. Therefore, some
variant of a sarcomatous tumor seemed plausible, and the preop-
erative surgical plan was to undergo abdominal exploration and
perform a gross total resection.
The typical pathologic appearance of IF includes spindle cells
with many blood vessels arranged in a hemangiopericytoma-like
pattern. However, this tumor is marked by its histologic heteroge-
neity and overlap with a number of other tumors and masses,
including congenital mesoblastic nephroma and hemangioma
[16,17]. IHC often shows positivity for vimentin and a lack of
markers associated with myogenic or vascular tissue. Importantly,
the t(12; 15) translocation, which causes ligand-independent acti-
vation of a tyrosine kinase leading to unchecked cell proliferation,
has been identiﬁed in cases of IF and has since become a signiﬁcant
ﬁnding in establishing the diagnosis [18].
Complete surgical resection is the treatmentof choice for IFwhen
reasonably feasible [19]. These tumors rarelydemonstrate lymphatic
spread so lymph node sampling is unnecessary [20]. Because IF
generally demonstrates anexcellent response to chemotherapywith
sarcoma based regimens, the use of neoadjuvant chemotherapy has
been recommended in some cases in order tominimize the need for
mutilating resections and amputations [4,20]. However, given its
tendency toward complicated presentations, IF arising from the in-
testine is unlikely to allow for preoperative therapy tobe considered.
The previously reported cases of IF arising from bowel have all re-
ported good outcomes, despite their complicated initial pre-
sentations which precluded any systematic preoperative evaluation
(Table 1). None of these patients, including the two described here,
received adjuvant therapy following resection and there have been
no follow-up reports of recurrence.
In conclusion, we report two cases of a rarely seen IF located
within the small bowel. Unlike all previous reports of IF arising from
bowel, one of our patients did not present with obstruction or
perforation, but rather as an incidental ﬁnding at a routine well-child
appointment. Although extremely uncommon, IF should be in the
differential for a mass arising from the bowel. If negative margins are
achieved with surgical resection, adjuvant chemotherapy can be
avoided in the absence ofmetastatic disease. Even in cases presenting
with obstruction or perforation, disease-free survival is excellent.References
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